CORCEPT THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 17 Mar 2026)
What this means for you
Not registered yet, but its 04 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98208880
- Mark type
- Design + words
- Filed
- 04 Oct 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Joel R. Feldman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; Pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; Pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders
Owner
- Corcept Therapeutics Incorporated, Redwood City, CA, US
- Corcept Therapeutics Incorporated, Menlo Park, CA, US
Prior registrations
Prosecution history
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2026 — SOU EXTENSION 4 GRANTED
- 16 Mar 2026 — SOU EXTENSION 4 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2026 — SOU EXTENSION 3 GRANTED
- 02 Mar 2026 — SOU EXTENSION 3 FILED
- 02 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2025 — SOU EXTENSION 2 GRANTED
- 19 Aug 2025 — SOU EXTENSION 2 FILED
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2025 — SOU EXTENSION 1 GRANTED
- 27 Feb 2025 — SOU EXTENSION 1 FILED